Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term SURGERY. Found 10 abstracts

Coups EJ, Park BJ, Feinstein MB, Steingart RM, Egleston BL, Wilson DJ, Ostroff JS. Physical Activity among Lung Cancer Survivors: Changes across the Cancer Trajectory and Associations with Quality of Life. Cancer Epidemiology Biomarkers & Prevention. 2009 Feb;18(2):664-72.   PMCID: PMC2674013
Eisenberg BL, Harris J, Blanke CD, Demetri GD, Heinrich MC, Watson JC, Hoffman JP, Okuno S, Kane JM, von Mehren M. Phase II Trial of Neoadjuvant/Adjuvant Imatinib Mesylate (IM) for Advanced Primary and Metastatic/Recurrent Operable Gastrointestinal Stromal Tumor (GIST): Early Results of RTOG 0132/ACRIN 6665. Journal of surgical oncology. 2009 Jan;99(1):42-7.   PMCID: PMC2606912
Rothman J, Egleston B, Wong YN, Iffrig K, Lebovitch S, Uzzo RG. Histopathological Characteristics of Localized Renal Cell Carcinoma Correlate With Tumor Size: A SEER Analysis. Journal of Urology. 2009 Jan;181(1):29-33.   PMCID: PMC2782573
Bilimoria KY, Palis B, Stewart AK, Bentrem DJ, Freel AC, Sigurdson ER, Talamonti MS, Ko CY. Impact of tumor location on nodal evaluation for colon cancer. Diseases of the Colon & Rectum. 2008 Feb;51(2):154-61.
Bradbury AR, Ibe CN, Dignam JJ, Cummings SA, Verp M, White M, Artioli G, Dudlicek L, Olopade OL. Uptake and timing of bilateral prophylactic salpingo-oophorectomy among BRCA1 and BRCA2 mutation carriers. Genetics in Medicine. 2008 Mar;10(3):161-6.
Wahl AO, Rademaker A, Kiel KD, Jones EL, Marks LB, Croog V, McCormick BM, Hirsch A, Karkar A, Motwani SB, Tereffe W, Yu TK, Sher D, Silverstein J, Kachnic LA, Kesslering C, Freedman GM, Small W. Multi-institutional review of repeat irradiation of chest wall and breast for recurrent breast cancer. International Journal of Radiation Oncology Biology Physics. 2008 Feb;70(2):477-84.
Friebel TM, Domchek SM, Neuhausen SL, Wagner T, Evans DG, Isaacs C, Garber JE, Daly MB, Eeles R, Matloff E, Tomlinson G, Lynch HT, Tung N, Blum JL, Weitzel J, Rubinstein WS, Ganz PA, Couch F, Rebbeck TR. Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriers. Clinical Breast Cancer. 2007 Dec;7(11):875-82.
Hawley ST, Lantz PM, Janz NK, Salem B, Morrow M, Schwartz K, Liu LH, Katz SJ. Factors associated with patient involvement in surgical treatment decision making for breast cancer. Patient education and counseling. 2007 Mar;65(3):387-95.
Winter WE, Maxwell GL, Tian CQ, Carlson JW, Ozols RF, Rose PG, Markman M, Armstrong DK, Muggia F, McGuire WP. Prognostic factors for stage III epithelial ovarian cancer: A Gynecologic Oncology Group Study. Journal of Clinical Oncology. 2007 Aug;25(24):3621-7.
Fang CY, Miller SM, Malick J, Babb J, Engstrom PF, Daly MB. Psychosocial correlates of intention to undergo prophylactic oophorectomy among women with a family history of ovarian cancer. Prev Med. 2003 Nov;37(5):424-31.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term SURGERY

SURGERY WOMEN SURVIVAL RESECTION METAANALYSIS PROGNOSTIC-FACTORS POPULATION OVARIAN-CANCER breast cancer surgery BREAST-CANCER RISK FOLLOW-UP LOCAL-REGIONAL RECURRENCE PREFERENCES ATTITUDES RELIABILITY TUMOR DOSE hyperthermia THERAPY pathology locally advanced GIST kidney genetic testing hereditary breast cancer CONSERVATION THERAPY HOSPITAL VOLUME perceived risk EXERCISE CAPACITY PSYCHOLOGICAL IMPACT SALVAGE MASTECTOMY ACTIVITY QUESTIONNAIRE local recurrence HORMONE REPLACEMENT THERAPY PACLITAXEL PROGNOSIS RECOMMENDATIONS STAGE REPRODUCTIVE AGE-GROUP renal cell carcinoma nodes BREAST-CANCER PREOPERATIVE PULMONARY REHABILITATION SUSCEPTIBILITY metastatic GIST surgical treatment LEIOMYOSARCOMAS GENE MUTATION colon neoplasms CONSERVING BRCA2 prophylactic salpingo-oophorectomy SALPINGO-OOPHORECTOMY colectomy CARCINOMA RADIATION-THERAPY MEASURES MORTALITY RESIDUAL DISEASE MINIMUM NUMBER GIST COLORECTAL-CANCER KeyWords Plus: HYPERTHERMIA CARCINOMA-IN-SITU REDUCTION INCREASED RISK REPRODUCIBILITY RECURRENCE MASTECTOMY SURVEILLANCE DECISION-MAKING IMATINIB FAMILY-HISTORY benefits LOCAL THERAPY National Cancer Data Base INFORMATION GROUP EXPERIENCE SEER program staging radiotherapy BRCA1 CISPLATIN PRIMARY PERITONEAL CARCINOMA SURGICAL CYTOREDUCTION ovarian cancer PREVENTIVE BRCA2 MUTATIONS LYMPH-NODES PATHOLOGICAL FEATURES PATTERNS SURGICAL-MANAGEMENT prophylactic oophorectomy CARE PENETRANCE involvement neoadjuvant imatinib CANCER INTRAPERITONEAL TREATMENT ALTERNATIVES lymph repeat irradiation decision making toxicity PUBLIC-HEALTH PHYSICIANS MANAGEMENT HIGH-DOSE CARBOPLATIN RANDOMIZED-TRIAL
Last updated on Friday, January 03, 2020